Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFRONYL for Intermittent claudication: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where NAFRONYL was used for Intermittent claudication.

Most Reported Side Effects for NAFRONYL

Side Effect Reports % Deaths Hosp.
Acute kidney injury 22 19.0% 3 20
Hepatic cytolysis 19 16.4% 19 13
Toxicity to various agents 19 16.4% 19 13
Acute pulmonary oedema 18 15.5% 18 12
Cardiac disorder 17 14.7% 17 11
Lactic acidosis 14 12.1% 2 9
Synovitis 14 12.1% 14 13
Cerebral haemorrhage 13 11.2% 0 0
Anaemia 12 10.3% 0 0
Coronary artery stenosis 12 10.3% 12 11
Encephalopathy 12 10.3% 12 7
Renal cell carcinoma 12 10.3% 0 0
Respiratory depression 12 10.3% 12 7
Drug abuse 11 9.5% 11 10
Hyperkalaemia 11 9.5% 1 11

Other Indications for NAFRONYL

Product used for unknown indication (63) Thromboangiitis obliterans (12) Peripheral vascular disorder (8) Peripheral arterial occlusive disease (7)

Other Drugs Used for Intermittent claudication

CILOSTAZOL (70) CLOPIDOGREL BISULFATE (23) ASPIRIN (20) RIVAROXABAN (15) PENTOXIFYLLINE (13) ATORVASTATIN (11) ROSUVASTATIN (11) PREGABALIN (10) IODIXANOL (6) OMNISCAN (6)

Related Pages

NAFRONYL Full Profile All Intermittent claudication Drugs NAFRONYL Demographics NAFRONYL Timeline